Amparo Pérez-Ferriols Selected Research

Amparo Pérez-Ferriols Research Topics

Disease

7	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 09/2005
2	Solar Urticaria 03/2024 - 01/2023
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2023 - 04/2015
2	Infections 01/2023 - 09/2019
2	Photoallergic Dermatitis (Photoallergy) 08/2020 - 04/2005
2	Atopic Dermatitis (Atopic Eczema) 05/2020 - 01/2017
2	Neoplasms (Cancer) 09/2019 - 04/2015
2	Mycosis Fungoides 05/2019 - 04/2015
1	Vitiligo 04/2024
1	Mpox (monkeypox) 03/2024
1	Anetoderma 03/2024
1	Bullous Pemphigoid (Pemphigoid) 03/2024
1	Angiomatosis 10/2023
1	Allergic Contact Dermatitis 09/2023
1	Lymphoma (Lymphomas) 01/2023
1	Necrosis 06/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Non-Langerhans-Cell Histiocytosis (Histiocytosis, Non Langerhans Cell) 01/2021
1	Mucinoses 08/2020
1	Hypersensitivity (Allergy) 08/2020
1	Alopecia Areata 05/2020
1	Dyslipidemias (Dyslipidemia) 05/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2020
1	Acneiform Eruptions 02/2020
1	Colorectal Neoplasms (Colorectal Cancer) 02/2020
1	Lymphomatoid Papulosis 01/2020
1	Squamous Cell Carcinoma of Head and Neck 09/2019
1	Dermatitis 09/2019
1	Lichen Planus (Lichen Ruber Planus) 09/2019
1	Ulcer 09/2019
1	Latent Tuberculosis 09/2019
1	Tuberculosis (Tuberculoses) 09/2019
1	Purpura 08/2019
1	Multiple Hamartoma Syndrome (Cowden's Disease) 05/2019
1	Disease Progression 04/2019
1	Skin Neoplasms (Skin Cancer) 01/2019
1	Eosinophilic Fasciitis 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Skin Diseases (Skin Disease) 04/2015
1	Primary Cutaneous Anaplastic Large Cell Lymphoma 04/2015
1	Follicular Mucinosis 04/2005

Drug/Important Bio-Agent (IBA)

3	Omalizumab (Xolair)FDA Link 03/2024 - 01/2023
2	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 03/2024 - 03/2024
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 09/2019
1	upadacitinibIBA 04/2024
1	Propranolol (Inderal)FDA LinkGeneric 10/2023
1	Interleukin-17 (Interleukin 17)IBA 09/2023
1	Brentuximab VedotinIBA 01/2023
1	guselkumabIBA 01/2022
1	Ustekinumab (CNTO 1275)FDA Link 01/2022
1	lenvatinibIBA 06/2021
1	secukinumabIBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 08/2020
1	Chlorpromazine (Thorazine)FDA Link 08/2020
1	EnzymesIBA 05/2020
1	dupilumabIBA 05/2020
1	Biomarkers (Surrogate Marker)IBA 02/2020
1	afliberceptIBA 02/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	pembrolizumabIBA 09/2019
1	Isoniazid (Ftivazide)FDA LinkGeneric 09/2019
1	Sunitinib (Sutent)FDA Link 08/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2019
1	TensinsIBA 05/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2019
1	ixekizumabIBA 04/2019
1	Ficusin (Psoralen)IBA 01/2019
1	SteroidsIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 04/2015
1	golimumab FDA Link 12/2014
1	Etanercept (Enbrel)FDA Link 09/2005
1	Captopril (Capoten)FDA LinkGeneric 04/2005
1	Antihypertensive Agents (Antihypertensives)IBA 04/2005

Therapy/Procedure

8	Therapeutics 02/2020 - 09/2005
2	Phototherapy (Light Therapy) 01/2021 - 01/2017
2	Aftercare (After-Treatment) 09/2019 - 05/2019
1	PUVA Therapy 01/2020
1	Immunotherapy 09/2019
1	Biological Therapy 09/2019
1	Complementary Therapies (Alternative Medicine) 04/2019
1	Photopheresis 01/2019